Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00800280 · ClinicalTrials.gov registry record · Phase 1
Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body
A Phase 1 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00800280 is a Phase 1 study that was terminated before completion, run by Pfizer. The registered enrollment target is 12 participants.
The verdict
NCT00800280, a Phase 1 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to estimate the effects of multiple doses of cimetidine on the pharmacokinetics of a single dose of PD 0332334 and to evaluate the safety and tolerability of PD 0332334 when co-administered with cimetidine.
Interventions
- DRUG PD 0332334
- DRUG cimetidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00800280
The ClinicalTrials.gov registry entry for NCT00800280 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PD 0332334 is the first listed.
NCT00800280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00800280 about?
NCT00800280 is a clinical study titled "Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body". The purpose of this study is to estimate the effects of multiple doses of cimetidine on the pharmacokinetics of a single dose of PD 0332334 and to evaluate the safety and tolerability of PD 0332334 when co-administered with cimetidine.
What is the current status of trial NCT00800280?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2009-01. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00800280?
The interventions under investigation include: PD 0332334 (DRUG), cimetidine (DRUG).
Who is sponsoring clinical trial NCT00800280?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.